Optimizing TAVR Denial Management: Automation for Complex Cardiac Procedures
Effective **TAVR denial management** is critical for maintaining revenue integrity for this high-cost, high-acuity cardiac procedure. Klivira automates the complex appeal workflows specific to Transcatheter Aortic Valve Replacement.
Transcatheter Aortic Valve Replacement (TAVR) procedures are often subject to rigorous medical necessity reviews, leading to a high potential for denials across commercial, Medicare Advantage, and Medicaid managed care plans. Manual denial processing for TAVR cases, with their intricate clinical documentation and frequent need for peer-to-peer review, places a significant burden on revenue cycle teams. Klivira transforms this challenge into an opportunity for efficiency and increased revenue recovery.
The Challenge of TAVR Denial Management
TAVR procedures are high-cost and high-acuity, frequently flagged for medical necessity and site-of-service review by payers. Denials often stem from insufficient documentation of severe aortic stenosis, symptom correlation, or failure to meet specific risk stratification criteria. Managing these appeals manually involves parsing complex X12 CARC/RARC codes and navigating payer-specific policies, leading to significant rework and potential timely-filing breaches.
Common TAVR Denial Themes and Root Causes
TAVR denials frequently involve medical necessity, often citing insufficient evidence of severe symptomatic aortic stenosis or failure to meet appropriate use criteria. Site-of-service denials are also prevalent, especially for elective cases, where payers may challenge an inpatient vs. outpatient setting. Additionally, documentation gaps regarding prior line therapies, multidisciplinary heart team evaluations, or contraindications for surgical AVR contribute to appeal complexity.
Essential Documentation for TAVR Appeal Packets
- Echocardiography reports confirming severe aortic stenosis (valve area, mean gradient).
- Clinical notes detailing symptoms (dyspnea, angina, syncope) and their correlation with aortic stenosis.
- Heart team meeting minutes documenting consensus for TAVR and patient risk stratification.
- Cardiac catheterization reports, if performed, confirming coronary anatomy and hemodynamics.
- Documentation of prior medical management for heart failure or other comorbidities.
- Imaging studies (CT angiogram) used for annular sizing and vascular access planning.
Klivira's Automated Approach to TAVR Denial Management
Klivira's platform streamlines TAVR denial workflows by automating critical steps from intake to appeal submission. We ingest denials from X12 835 and 277 transactions, as well as payer portals, normalizing CARC/RARC codes and payer-specific variations into a unified taxonomy. This precision ensures accurate routing to claim correction, appeal, or peer-to-peer pathways, crucial for high-value TAVR cases.
Key Automation Features for TAVR Appeals
- **Automated Appeal Packet Assembly:** Klivira pulls TAVR-specific clinical documentation (echo reports, heart team notes, CT scans) from the EMR via FHIR, ensuring comprehensive appeal packets.
- **Intelligent Routing:** Denials are automatically categorized and routed based on TAVR-specific medical necessity criteria and site-of-service policies, reducing manual review.
- **Timely Filing Enforcement:** Proactive tracking of payer-specific appeal deadlines prevents costly missed windows for TAVR procedures.
- **Peer-to-Peer Scheduling:** For high-acuity TAVR denials, Klivira facilitates scheduling and tracking of peer-to-peer reviews with ordering clinicians.
- **Denial Pattern Analytics:** Identify recurring TAVR denial reasons by payer or facility to inform upstream PA submission improvements for future cases.
Improving Revenue Recovery for TAVR Procedures
By minimizing manual intervention and ensuring accurate, timely appeal submissions for TAVR, Klivira significantly reduces administrative costs associated with denial rework. Our system helps recover revenue that might otherwise be written off due to capacity constraints or documentation gaps. This operational efficiency contributes directly to the financial health of cardiac service lines handling TAVR.
Frequently asked questions
How does Klivira handle site-of-service denials for TAVR?
Klivira's denial routing logic identifies site-of-service denials and automatically gathers documentation supporting the medical necessity of the chosen setting (e.g., inpatient vs. outpatient), assembling it into the appeal packet for resubmission.
Can Klivira integrate with our EMR to pull TAVR clinical documentation?
Yes, Klivira leverages SMART on FHIR to securely access and pull relevant clinical documentation, such as echocardiograms, heart team notes, and CT reports, directly from your EMR to build comprehensive TAVR appeal packets.
What types of TAVR denial reasons does Klivira automate?
Klivira automates appeals for common TAVR denial reasons including medical necessity (e.g., insufficient severe aortic stenosis documentation), site-of-service appropriateness, and specific policy non-compliance, by normalizing X12 CARC/RARC codes and payer-specific local variations.
How does Klivira help prevent future TAVR denials?
Klivira provides detailed analytics on TAVR denial patterns by payer, reason, and provider. This feedback loop informs upstream prior authorization submission processes, enabling proactive adjustments to clinical documentation or submission strategies to reduce future denials.
Does Klivira support peer-to-peer reviews for TAVR denials?
Yes, for high-acuity TAVR denials requiring clinical discussion, Klivira routes scheduling requests to ordering clinicians and tracks the status of peer-to-peer reviews, ensuring timely engagement with payer medical directors.
Related coverage
Ready to automate this workflow?
See how Klivira automates prior authorizations for your team.
Request a demo